Cost-Effectiveness of Using LDL-Direct Versus Lipid-Panel as Part of the Inpatient Stroke Workup

Richard Lane1, Kunal Agrawal1, Royya Modir2

  • 1UC San Diego Hospital, 200 West Arbor Dr., San Diego, CA 92103, United States.

Insights

Using an LDL-direct test instead of a lipid panel for stroke patients can save healthcare systems significant money. This approach offers a more cost-effective method for managing dyslipidemia and guiding statin therapy.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Clinical Laboratory Science

Background:

  • Stroke and transient ischemic attack (TIA) workups often include lipid testing.
  • Accurate low-density lipoprotein cholesterol (LDL-C) measurement is crucial for guiding dyslipidemia management, including statin initiation.
  • Current practices may involve using a standard lipid panel, which includes LDL-C calculation.

Purpose of the Study:

  • To compare the cost-effectiveness of using an LDL-direct laboratory test versus a traditional lipid panel for inpatient stroke and TIA evaluations.
  • To assess the financial impact on both patients and the hospital system.
  • To evaluate the influence of accurate LDL-C on statin therapy initiation.

Main Methods:

  • Retrospective analysis of 1245 patients admitted for ischemic stroke or TIA between July 2016 and June 2019.
  • Cost analysis based on UCSD hospital billing data from June 2020.
  • Examination of statin initiation in patients not previously on therapy.

Main Results:

  • The study included 1245 patients (87% ischemic stroke, 13% TIA).
  • Utilizing LDL-direct testing instead of a lipid panel could result in $77,545 in savings over three years, a 33% cost reduction.
  • 43% of patients were initiated on statin therapy during their admission.

Conclusions:

  • The LDL-direct test is a more cost-effective option than the lipid panel for assessing LDL-C in stroke and TIA patients.
  • This approach offers potential financial benefits to both patients and the healthcare system.
  • Optimizing LDL-C measurement can improve dyslipidemia management and therapeutic decisions.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
156
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
84
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
442
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
227
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
97
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
483